Table 1 Comparison of baselines characteristics among three groups.
Variable | IMN (n = 46) | DN (n = 25) | Others (n = 16) | F/χ2 | P值 |
|---|---|---|---|---|---|
Male (n, %) | 29(63.04%) | 17(68.00%) | 9(56.25%) | 0.581 | 0.748 |
Age (Years) | 54.00 (49.00, 64.00) | 54.00 (46.50, 64.50) | 57.00 (40.25, 65.00) | 0.159 | 0.993 |
DM duration (Years) | 1.00 (0.31, 4.00) | 7.00 (3.00, 12.00)* | 3.00 (0.75, 10.00) | 15.922 | < 0.001 |
BMI (kg/m2) | 28.47 ± 3.74 | 26.69 ± 4.05 | 27.87 ± 4.93 | 1.559 | 0.216 |
DM family history (n, %) | 5(10.87%) | 5(20.00%) | 3(18.75%) | 1.541 | 0.521 |
DR (n, %) | 8(17.39%) | 20(80.00%)* | 1(6.25%)# | 35.042 | < 0.001 |
DPN (n, %) | 8(17.39%) | 15(60.00%)* | 6(37.50%) | 13.386 | 0.001 |
Hypertension (n, %) | 32(69.57%) | 23(92.00%)* | 15(93.75%) | 6.796 | 0.026 |
SBP (mmHg) | 146.41 ± 24.20 | 165.48 ± 30.72* | 143.38 ± 20.38# | 5.422 | 0.006 |
DBP (mmHg) | 88.80 ± 13.09 | 92.48 ± 13.53 | 87.94 ± 14.05 | 0.780 | 0.462 |
ALB (g/L) | 25.72 ± 6.00 | 30.92 ± 6.40* | 30.35 ± 9.05* | 5.929 | 0.004 |
BUN (mmol/L) | 4.60 (3.73, 5.44) | 6.92 (5.60, 9.94)* | 6.15 (5.10, 7.32)* | 22.520 | < 0.001 |
Scr (umol/L) | 66.85 (58.88, 75.41) | 96.10 (78.13, 136.29)* | 91.80 (65.67, 146.53)* | 22.174 | < 0.001 |
eGFR (ml/min·1.73m2) | 103.43 (92.16, 117.57) | 69.36 (49.03, 81.86)* | 69.68 (44.46, 110.73)* | 28.157 | < 0.001 |
UA (umol/L) | 352.42 (305.51, 440.05) | 333.24 (293.87, 389.36) | 356.77 (288.75, 470.37) | 0.896 | 0.639 |
TG (mmol/L) | 2.48 (1.55, 3.52) | 1.60 (0.90, 2.24)* | 1.91 (1.29, 3.95) | 10.787 | 0.005 |
TC (mmol/L) | 7.03 (6.00, 10.88) | 6.76 (4.75, 7.39)* | 6.03 (5.24, 8.11) | 6.039 | 0.049 |
FPG (mmol/L) | 6.06 (5.37, 7.36) | 7.91 (5.06, 9.63) | 6.86 (5.23, 7.85) | 3.087 | 0.214 |
HbA1c (%) | 6.70 (6.10, 7.25) | 7.70 (6.50, 9.40)* | 7.05 (6.50, 7.88) | 7.071 | 0.029 |
UTP (g/24 h) | 5.24 (4.11, 8.55) | 6.16 (3.49, 7.09) | 3.20 (2.51, 5.68)* | 7.274 | 0.026 |
anti-PLA2R antibody ≥ 14(RU/ml) | 37 (80.43) | 1 (4.00)* | 1 (6.25)* | 50.058 | < 0.001 |
